Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-063930

Director sold 6,000 shares at an average $58.84 ($353,040)

  • Director acquired 6,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
GRIFFIN MICHELLE RENEE Director 2020-12-14 Option exercise +6,000 $7.80 $46,800 6,000 D
GRIFFIN MICHELLE RENEE Director 2020-12-14 Sale −982 $57.42 $56,386 5,018 D
GRIFFIN MICHELLE RENEE Director 2020-12-14 Sale −3,367 $58.96 $198,518 1,651 D
GRIFFIN MICHELLE RENEE Director 2020-12-14 Sale −1,651 $59.44 $98,135 0 D
Derivatives
GRIFFIN MICHELLE RENEE Director 2020-12-14 Option exercise · Stock Option (Right to Buy) −6,000 101,000 D
Open-market sales · 6,000 sh · avg $58.84 · $353,040
Loading xslF345X03/doc4.xml…